MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Evaluating a Mobile Health Application Intervention for Caregiver Instruction in Manual Therapy for Chemotherapy-Induced Peripheral Neuropathy

Not Applicable

Not yet recruiting

Conditions: Chemotherapy-Induced Peripheral Neuropathy
Malignant Solid Neoplasm

First Posted Date: 2025-04-25

Last Posted Date: 2025-05-13

Lead Sponsor: Mayo Clinic

Target Recruit Count: 300

Registration Number: NCT06945380

Locations: 🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States

The Impact of Biological Mechanisms of Aging on Response Variability to Resistance Training in Older Adults

Not Applicable

Not yet recruiting

Conditions: Aging
Mobility Disability

First Posted Date: 2025-04-23

Last Posted Date: 2025-04-23

Lead Sponsor: Mayo Clinic

Target Recruit Count: 300

Registration Number: NCT06940037

Locations: 🇺🇸
Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

High Resolution Gastric Mapping and Gastroduodenal Manometry

Not Applicable

Not yet recruiting

Conditions: Dyspepsia

First Posted Date: 2025-04-23

Last Posted Date: 2025-04-23

Lead Sponsor: Mayo Clinic

Target Recruit Count: 50

Registration Number: NCT06941545

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma

Phase 2

Not yet recruiting

Conditions: Recurrent Multiple Myeloma
Refractory Multiple Myeloma

Interventions: Procedure: Biopsy Procedure
Procedure: Biospecimen Collection
Procedure: Bone Marrow Aspiration
Procedure: Bone Marrow Biopsy
Biological: Ciltacabtagene Autoleucel
Procedure: Computed Tomography
Drug: Cyclophosphamide
Drug: Dasatinib
Drug: Fludarabine
Procedure: Positron Emission Tomography
Drug: Quercetin

First Posted Date: 2025-04-23

Last Posted Date: 2025-05-13

Lead Sponsor: Mayo Clinic

Target Recruit Count: 44

Registration Number: NCT06940297

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Feasibility and Effect of Wrapping Nerves With a Multi-Layer Perinatal Tissue Allograft During Prostatectomy

Not Applicable

Not yet recruiting

Conditions: Localized Prostate Carcinoma
Stage I Prostate Cancer AJCC v8
Stage II Prostate Cancer AJCC v8
Stage III Prostate Cancer AJCC v8

First Posted Date: 2025-04-23

Last Posted Date: 2025-05-18

Lead Sponsor: Mayo Clinic

Target Recruit Count: 25

Registration Number: NCT06940271

Locations: 🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States
🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States

Hand Perfusion and Pulse Oximetry Performance

Not yet recruiting

Conditions: Oxygen Saturation

First Posted Date: 2025-04-13

Last Posted Date: 2025-04-13

Lead Sponsor: Mayo Clinic

Target Recruit Count: 20

Registration Number: NCT06925646

Locations: 🇺🇸
Mayo Clinic Department of Anesthesiology, Rochester, Minnesota, United States

Transcutaneous Spinal Stimulation for Children and Youth With Spina Bifida

Not Applicable

Not yet recruiting

Conditions: Myelomeningocele
Spina Bifida

First Posted Date: 2025-04-09

Last Posted Date: 2025-04-09

Lead Sponsor: Mayo Clinic

Target Recruit Count: 30

Registration Number: NCT06918119

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer

Phase 2

Recruiting

Conditions: Lung Non-Small Cell Carcinoma
Stage IB Lung Cancer AJCC v8
Stage II Lung Cancer AJCC v8
Stage III Lung Cancer AJCC v8
Stage IIIA Lung Cancer AJCC v8
Stage IIIB Lung Cancer AJCC v8

Interventions: Procedure: Biospecimen Collection
Biological: Cemiplimab
Biological: Fianlimab
Procedure: Magnetic Resonance Imaging
Procedure: Surgical Procedure

First Posted Date: 2025-04-09

Last Posted Date: 2025-05-02

Lead Sponsor: Mayo Clinic

Target Recruit Count: 60

Registration Number: NCT06918132

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

A Randomized Controlled Trial of Menopausal Tool/App for Women

Not Applicable

Conditions: Menopausal Symptoms
Menopause Symptom Management

First Posted Date: 2025-04-09

Last Posted Date: 2025-05-08

Lead Sponsor: Mayo Clinic

Target Recruit Count: 450

Registration Number: NCT06919887

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors

Phase 3

Recruiting

Conditions: Childhood Malignant Solid Neoplasm
Childhood Malignant Thoracic Neoplasm
Malignant Neck Neoplasm
Malignant Abdominal Neoplasm
Malignant Pelvic Neoplasm
Metastatic Childhood Malignant Solid Neoplasm

Interventions: Procedure: Biospecimen Collection
Procedure: Near Infrared Imaging
Drug: Pafolacianine Sodium
Procedure: Surgical Procedure

First Posted Date: 2025-04-08

Last Posted Date: 2025-04-17

Lead Sponsor: Mayo Clinic

Target Recruit Count: 20

Registration Number: NCT06915727

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Home Terms & Conditions Privacy Policy